Drug Information

Drug General Information
Drug ID
D0L5UC
Former ID
DNC012065
Drug Name
5-Ethyl-3-methyl-5-phenyl-oxazolidine-2,4-dione
Drug Type
Small molecular drug
Indication Discovery agent Investigative [533048]
Formula
C12H13NO3
Canonical SMILES
CCC1(C(=O)N(C(=O)O1)C)C2=CC=CC=C2
InChI
1S/C12H13NO3/c1-3-12(9-7-5-4-6-8-9)10(14)13(2)11(15)16-12/h4-8H,3H2,1-2H3
InChIKey
BWNMMRKYEBCJHN-UHFFFAOYSA-N
PubChem Compound ID
12488718
Target and Pathway
Target(s) Sodium channel Target Info Inhibitor [533048]
Voltage-gated sodium channel subunit alpha Nav1.3 Target Info Inhibitor [533048]
KEGG Pathway Dopaminergic synapse
Reactome Interaction between L1 and AnkyrinsR-HSA-445095:Interaction between L1 and Ankyrins
References
Ref 533048J Med Chem. 1989 Jul;32(7):1577-80.Sodium channel binding and anticonvulsant activities for the enantiomers of a bicyclic 2,4-oxazolidinedione and monocyclic models.
Ref 533048J Med Chem. 1989 Jul;32(7):1577-80.Sodium channel binding and anticonvulsant activities for the enantiomers of a bicyclic 2,4-oxazolidinedione and monocyclic models.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.